Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuanhu Qutong is a Traditional Chinese Medicine (TCM) formulation developed by Lunan Hope Pharmaceutical for the treatment of gouty arthritis. The formulation is typically prepared as granules or a mixture and is intended for oral administration to alleviate the symptoms of acute gout attacks, including joint pain, swelling, and inflammation. Clinical development is currently in Phase II, with studies such as CTR20260553 evaluating its efficacy and safety in patients with gouty arthritis. The name 'Chuanhu' typically refers to its primary herbal components, which often include Chuan Shan Long (*Dioscorea nipponica*) and Hu Zhang (*Polygonum cuspidatum*).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chuanhu Qutong.